NHGRI logo

Centers of Excellence in Genomic Science

The Centers of Excellence in Genomic Science (CEGS) program supports the formation of multi-investigator, interdisciplinary research teams to develop novel and innovative genomic research projects, using the data sets and technologies developed by the Human Genome Project.


The CEGS will conduct highly innovative research designed to develop new concepts, methods, technologies, or ways to analyze data that will substantially advance the state of the art in genomic approaches to the study of a biological problem. Thus, CEGS research will ultimately foster the wider application of comprehensive, high-throughput genomics methods to the study of human biology and disease.

A CEGS will require visionary leadership and strong management. While use of the Multi-PI option is permitted, the requirement for the contact PI to devote significant effort is intended to provide the focus needed to drive the project toward its goals.

Each CEGS will include an education and outreach component that leverages the strengths of the CEGS and its investigators to add value to the genomics capabilities of the host institution, region and nation.

A CEGS grant offers a rich opportunity for promoting diversity in the NHGRI/NIH-funded biomedical, behavioral, clinical and social sciences workforce. Therefore, CEGS grantees are encouraged to apply for a Diversity Action Plan R25 grant.


A successful CEGS must include ALL of the following:

  • A CEGS is highly innovative, being designed to develop new concepts, methods, technologies, or ways to produce or analyze comprehensive data sets, or on a particular genome-scale biomedical problem, or on other ways to develop and use genomic approaches for understanding biological systems and/or significantly furthering the application of genomic knowledge, data and methods towards clinical applications.
  • A CEGS proposes a very substantial advance to addressing a critical issue in genomic science or genomic medicine. Achieving a substantial advance entails risk; this is balanced by the potential for very high payoff and requires an outstanding scientific plan and effective management strategy.
  • A CEGS is a tightly focused project implemented by a multi-investigator, interdisciplinary team working in a highly integrated fashion. Components of the program must be interdependent, not simply related. Synergy and integration are key.
  • A CEGS will lay out a specific and substantive "product" that can be identified as having been the outcome of CEGS funding.
  • A CEGS will take on challenging aspects of a problem, including ones that have slowed progress in the chosen area of research.
  • A CEGS will increase the pool of professional scientists and engineers able to work in or use genomics, by offering innovative, substantive education and outreach opportunities across appropriate disciplines. It will integrate the training of new and broaden the training of established investigators. Graduate students and postdoctoral fellows, at a minimum, should participate in the research; however, that participation alone is insufficient as an education and outreach effort.

Additional characteristics of a CEGS:

  • A CEGS project may include an ELSI component if it is integrated with and closely related to the main focus or theme of the project.
  • Establishing a CEGS at an institution must add value beyond ongoing activities in genomics at that institution.
  • A CEGS project may propose very substantial improvement in current technology, to increase throughput and decrease cost.
  • A CEGS may choose a cell, organism, tissue, pathway, or disease as a model system in which to develop the concepts or methods, but those concepts or methods must be broadly applicable well beyond the chosen example.


  • The obvious next step in a project or field, which could be accomplished by assembling state-of-the-art components and innovating at the level of a typical R01;
  • A program project;
  • Infrastructure for an existing program or department;
  • Primarily for the collection of a dataset in the absence of a novel concept or methodological approach;
  • "Only" outstanding science that fails to meet the criteria required of a CEGS.

View a printable version of this section.

Funding Opportunities


  • PAR-19-204 Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional)
    Expiration Date: May 21, 2021


  • PAR-16-436 Centers of Excellence in Genomic Science (CEGS) (RM1) (Expired)
    Expiration Date: Feb 28, 2019

    • NOT-MH-16-028 Notice of NIMH's Participation in PAR-16-436 "Centers of Excellence in Genomic Science (CEGS) (RM1)"

Program Staff

Program Directors

Lisa D. Brooks, Ph.D.
Lisa Brooks, Ph.D.
  • Program Director, Genomic Variation Program
  • Division of Genome Sciences

Scientific Program Analysts

Harry Wedel
Harry Wedel
  • Scientific Program Analyst
  • Division of Genome Sciences

Last updated: August 13, 2019